Encephalopathy in ifosfamide-treated patients
- 1 November 1992
- journal article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 86 (5) , 521-525
- https://doi.org/10.1111/j.1600-0404.1992.tb05136.x
Abstract
Acute encephalopathy following treatment with ifosfamide and mesna was observed in 5 (4 women and 1 men) of 28 patients (17.8%), with advanced sarcoma, lymphoma or ovarian carcinoma. This appeared within 2 to 7 days following the first dose of ifosfamide treatment, and included mental status changes, urinary incontinence, weakness, seizure activity, altered consciousness and psychiatric manifestations. Three cases were fatal, while two patients recovered completely. Brain CT and morphometric studies were normal in all the patients. Associated findings were myelosuppression, renal failure and electrolyte alterations.Keywords
This publication has 19 references indexed in Scilit:
- Encephalopathy with hyponatremia and inappropriate arginine vasopressin secretion following an intravenous ifosfamide infusionAnnals of Oncology, 1990
- CT in the differential diagnosis between Alzheimer's disease and vascular dementiaActa Neurologica Scandinavica, 1987
- ENCEPHALOPATHY WITH RAPID INFUSION IFOSFAMIDE/MESNAThe Lancet, 1987
- Central nervous system toxicity following the treatment of pediatric patients with ifosfamide/mesna.Journal of Clinical Oncology, 1986
- Ifosfamide-pharmacology, safety and therapeutic potentialCancer Treatment Reviews, 1985
- IFOSFAMIDE/MESNA AND ENCEPHALOPATHYThe Lancet, 1985
- ENCEPHALOPATHY ASSOCIATED WITH IFOSPHAMIDE/MESNA THERAPYThe Lancet, 1985
- Computed tomography and aging of the brain.Radiology, 1981
- Frontal ventricular dimensions on normal computed tomographyAmerican Journal of Roentgenology, 1976
- Use of computerized tomography in senile dementia.Journal of Neurology, Neurosurgery & Psychiatry, 1975